Annovation Biopharma

In January 2015 The Medicines Company (NASDAQ: MDCO) acquired Annovation BioPharma to revolutionize anesthesia and critical care medicine.

Headquarters	Cambridge, MA
Pipeline	Phase 1b trials in progress at The Medicines Company